Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Progression-Free and Overall Survival of Patients With ALK Rearrangement–Positive Non–Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib
PaperCitations, authors & open-access status
Progression-Free and Overall Survival of Patients With ALK Rearrangement–Positive Non–Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 41 citations, 2016 year and closed oa status.
41
Citations
2016
Year
closed
OA Status